↓ Skip to main content

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases

Overview of attention for article published in Molecular Diagnosis & Therapy, April 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#2 of 386)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
6 news outlets
blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
130 Mendeley
Title
Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
Published in
Molecular Diagnosis & Therapy, April 2019
DOI 10.1007/s40291-019-00392-3
Pubmed ID
Authors

Panayiota Papasavva, Marina Kleanthous, Carsten W. Lederer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 130 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 130 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 12%
Researcher 15 12%
Student > Ph. D. Student 14 11%
Student > Bachelor 10 8%
Unspecified 4 3%
Other 17 13%
Unknown 55 42%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 34 26%
Medicine and Dentistry 9 7%
Agricultural and Biological Sciences 8 6%
Unspecified 4 3%
Philosophy 3 2%
Other 14 11%
Unknown 58 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 59. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 February 2022.
All research outputs
#621,539
of 23,056,273 outputs
Outputs from Molecular Diagnosis & Therapy
#2
of 386 outputs
Outputs of similar age
#15,668
of 351,585 outputs
Outputs of similar age from Molecular Diagnosis & Therapy
#1
of 9 outputs
Altmetric has tracked 23,056,273 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 386 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,585 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them